TITLE

Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome

AUTHOR(S)
Stevens, A; Clayton, P; Tatò, L; Yoo, H W; Rodriguez-Arnao, M D; Skorodok, J; Ambler, G R; Zignani, M; Zieschang, J; Della Corte, G; Destenaves, B; Champigneulle, A; Raelson, J; Chatelain, P
PUB. DATE
February 2014
SOURCE
Pharmacogenomics Journal;Feb2014, Vol. 14 Issue 1, p54
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Individual responses to growth hormone (GH) treatment are variable. Short-term generation of insulin-like growth factor-I (IGF-I) is recognized as a potential marker of sensitivity to GH treatment. This prospective, phase IV study used an integrated genomic analysis to identify markers associated with 1-month change in IGF-I (ΔIGF-I) following initiation of recombinant human (r-h)GH therapy in treatment-naïve children with GH deficiency (GHD) (n=166) or Turner syndrome (TS) (n=147). In both GHD and TS, polymorphisms in the cell-cycle regulator CDK4 were associated with 1-month ΔIGF-I (P<0.05). Baseline gene expression was also correlated with 1-month ΔIGF-I in both GHD and TS (r=0.3; P<0.01). In patients with low IGF-I responses, carriage of specific CDK4 alleles was associated with MAPK and glucocorticoid receptor signaling in GHD, and with p53 and Wnt signaling pathways in TS. Understanding the relationship between genomic markers and early changes in IGF-I may allow development of strategies to rapidly individualize r-hGH dose.
ACCESSION #
94007320

 

Related Articles

  • Detecting growth hormone misuse in athletes. Holt, Richard I. G. // Indian Journal of Endocrinology & Metabolism;2013 Supplement, Vol. 17 Issue S1, pS18 

    Athletes have been misusing growth hormone (GH) for its anabolic and metabolic effects since the early 1980s, at least a decade before endocrinologists began to treat adults with GH deficiency. Although there is an ongoing debate about whether GH is performance enhancing, recent studies suggest...

  • Fox-Fordyce Disease: Two Cases in Patients with Turner Syndrome. Patrizi, A.; Orlandi, C.; Neri, I.; Fanti, P. A.; Mazzanti, L. // Acta Dermato-Venereologica;03/18/99, Vol. 79 Issue 1, p83 

    Presents a case of fox-forcedyce in two patients with turner syndrome under treatment with growth hormone. Emphasis on keratin obstruction of the upper limits of the apocrine duct; Presence of spongiotic vesicles in eccrine gland acrosyringia; Manifestations of the syndrome.

  • Immunolocalization of Insulin-Like Growth Factor-I and its Immunoreactivity during Ovary Developmental Stages of Persian Sturgeon, Acipenser Persicus. Kamangar, Barzan Bahrami; Amiri, Bagher Mojazi; Rasaee, Mohammad Javad; Abtahi, Behrouz; Bahmani, Mahmoud // Yakhteh Medical Journal;Winter2010, Vol. 11 Issue 4, p432 

    Objective: Immunohistochemical localization and immunoreactivity of insulin-like growth factor-I (IGF-I) were investigated during the ovarian developmental stages in Persian sturgeon. In addition, the effects of growth hormone and thyroxine were investigated on IGF-I immunoreactivity in vitro....

  • Estrogen plus GH increases height for girls with Turner's syndrome. Kalvaitis, Katie // Endocrine Today;Apr2011, Vol. 9 Issue 4, p40 

    The article discusses research being done on the benefit of estrogen and growth hormone (GH) to girls with Turner's syndrome, referencing a study by Judith Ross et al, published in a 2011 issue "The New England Journal of Medicine."

  • Low-dose estrogen plus GH may optimize outcomes in patients with Turner syndrome. Adams, Stacey L.; Haigh, Christen // Endocrine Today;7/25/2008, Vol. 6 Issue 13, p6 

    The article discusses the findings of a study presented at the 90th Annual Meeting of the Endocrine Society which showed the benefit of low-dose estrogen plus growth hormone in girl patients with Turner syndrome. A double-blind, randomized, placebo-controlled trial in girls with Turner syndrome...

  • Factors predicting the response to growth hormone therapy in Taiwanese patients with Turner syndrome. Ying-Hua Huang; Fu-Sung Lo; Yang-Hau Van; Hsun-Hui Sui // International Journal of Pediatric Endocrinology;2013, Vol. 2013 Issue Suppl 1, p1 

    An abstract of the study "Factors Predicting the Response to Growth Hormone Therapy in Taiwanese Patients With Turner Syndrome" by Ying-Hua Huang et al is presented.

  • Growth Hormone Therapy.  // Current Medical Literature: GH & Growth Factors;2003, Vol. 18 Issue 1, p11 

    Presents citations and clinicians' notes on growth hormone therapy. Increase in muscle power after resistance training in growth hormone-deficient adults; Short-term growth hormone treatment in girls with Turner syndrome.

  • Citations and Clinicians' Notes: Growth hormone: Therapy.  // Current Medical Literature: GH & Growth Factors;2003, Vol. 18 Issue 4, p92 

    Presents a clinicians' notes related to growth hormone therapy. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height; Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors...

  • Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India. John, Mathew; Koledova, Ekaterina; Kumar, Kanakatte Mylariah Prasanna; Chaudhari, Harshal // International Journal of Endocrinology;10/27/2016, p1 

    In clinical practice, every year approximately 150,000 children are referred with short stature (SS) based on a cut-off of fifth percentile. The most important endocrine and treatable cause of SS is growth hormone deficiency (GHD). The lack of reliable data on the prevalence of GHD in India...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics